Role of Presenilins in Capacitative Calcium Entry

About the Research Project
Program
Award Type
Standard
Award Amount
$190,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000002
Acknowledgement
Summary
When the normal intracellular stores of calcium are depleted, a response is triggered inside the cell that leads to the influx of calcium from outside the cell. This process is known as capacitative calcium entry, or CCE. Dr. Tae-Wan Kim has found that mutations in presenilin 1 (PS1) or presenilin 2 (PS2) that cause inherited AD are associated with an impaired CCE response. It has also been found that treating cells with an inhibitor of the CCE response causes an increase in the expression of the protein Ab42. This suggests that the CCE response is coupled with the gamma secretase activity associated with PS1, and that it causes the production of Ab42. Dr. Kim is examining these relationships in more detail to determine whether the reduction of CCE is an early event in AD. He also hopes to determine whether increasing CCE response reduces gamma secretase activity. If it does, this result would raise the possibility that drugs that stimulate CCE could lead to the decreased production of Ab42 and the progression of AD.
Grants
Related Grants
Alzheimer's Disease Research
Tau, Aβ, and Network Degeneration in Alzheimer’s Disease
Active Dates
July 01, 2014 - June 30, 2017
Principal Investigator
Rik Ossenkoppele, PhD
Tau, Aβ, and Network Degeneration in Alzheimer’s Disease
Active Dates
July 01, 2014 - June 30, 2017

Principal Investigator
Rik Ossenkoppele, PhD
Alzheimer's Disease Research
Fingerprinting In Vivo and In Vitro Prion Strains
Active Dates
September 01, 2020 - November 30, 2022
Principal Investigator
Hyunjun Yang, PhD
Fingerprinting In Vivo and In Vitro Prion Strains
Active Dates
September 01, 2020 - November 30, 2022

Principal Investigator
Hyunjun Yang, PhD
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015

Principal Investigator
Guojun Bu, PhD